Evotec has extended its current research collaboration with Ono Pharmaceutical (Ono) and initiated a new discovery collaboration. Under the contract extension Evotec will provide integrated drug discovery activities,
Mylan Pharmaceuticals (Mylan) has received approval from the FDA for its Abbreviated New Drug Application (ANDA) for Topiramate Capsules (Sprinkle), 15mg and 25mg. Topiramate Capsules (Sprinkle) are the
The European regulatory authorities have approved Medivir’s marketing authorisation application in 14 European countries. The trademark for the product in Europe will be Xerclear. The company has claimed
Radient Pharmaceuticals (Radient) has entered into a collaboration agreement through its wholly owned subsidiary AMDL Diagnostics (ADI) with CeTeCancer to validate the effectiveness of its Onko-Sure in vitro
The third quarter results include after-tax special charges totaling $69 million (or $0.11 per diluted share) primarily for fixed asset write-offs related to the discontinuation of the company’s
EyeGate Pharma (EyeGate) has completed phase II study of its lead product candidate, EGP-437, for the treatment of anterior uveitis. In the study, EGP-437, a corticosteroid solution specifically
Inovio Biomedical (Inovio) has initiated phase I clinical study of Pennvax-B preventive DNA vaccine delivered using its proprietary electroporation technology. The multi-center study will be conducted at several
LHC Group (LHC) has signed a definitive agreement to acquire the assets of Feliciana Home Health (Feliciana). Net revenue for Feliciana during the most recent 12 months was
Pfizer has completed its acquisition of Wyeth following the receipt of regulatory approval from all government authorities required by the merger agreement and approval by Wyeth shareholders. Under
“Prometheus has a long and successful history of providing innovative diagnostics that complement targeted therapeutics to help physicians individualize patient care,” said Joseph M. Limber, president and chief
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.